Effect of autologous blood transfusion on the treatment of De Quervain's disease
Phase 2
Recruiting
- Conditions
- De Quervain's.Spontaneous rupture of synovium and tendon
- Registration Number
- IRCT2017081635382N4
- Lead Sponsor
- Vice Chancellor for research of Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Diagnosis of De Quervain's disease; age of 18 to 60 years; no history of rheumatic disorder such as rheumatoid arthritis; no history of depression and other mental disorders; no history of previous intervention for the treatment of De Quervain's disease.
Exclusion criteria: loss of follow-up.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Before the start of the intervention and after the end of the intervention. Method of measurement: visual analog scale.;Disability. Timepoint: Before the start of the intervention and after the end of the intervention. Method of measurement: Disabilities of the Arm, Shoulder and Hand (DASH) score.
- Secondary Outcome Measures
Name Time Method